Literature DB >> 20507838

The relationship between concentrations of magnesium and oxidized low density lipoprotein and the activity of platelet activating factor acetylhydrolase in the serum of patients with type 1 diabetes.

Małgorzata Wegner1, Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Bogna Wierusz-Wysocka, Anna Pioruńska-Mikołajczak, Maria Pioruńska-Stolzmann.   

Abstract

The study was aimed at comparing the concentration of metabolic parameters, the serum concentration of oxidized low density lipoproteins (oxLDL) and the activity of platelet activating factor acetylhydrolase (PAF-AH) in the relation to the serum concentration of magnesium (Mg) in patients with type 1 diabetes (DM1). DM1 patients (n=78) were divided into 2 groups: patients with low serum Mg concentration (<0.7 mmol/L, group 1, n=34) and patients with reference levels of Mg (>or=0.7 mmol/L, group 2, n=44). A control group (n=24) of healthy subjects was also recruited. Our results showed that DM1 patients had lower serum Mg concentrations than the control group. It was found that parameters of poor metabolic control and lipid profile are not related to the serum Mg concentration in DM1 patients. However, both the Mg concentration and the PAF-AH activity are independently related to the serum oxLDL concentration. In group 1 the oxLDL concentration and the PAF-AH activity were higher than in group 2, and the control group. Two groups of DM1 patients did not show any differences with regard to the metabolic control. Therefore, the oxidative modification of LDL and the higher activity of PAF-AH are related with the low Mg status; however, no relation has been observed between these parameters and the poor metabolic control in DM1 patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507838     DOI: 10.1684/mrh.2010.0207

Source DB:  PubMed          Journal:  Magnes Res        ISSN: 0953-1424            Impact factor:   1.115


  7 in total

Review 1.  The Role of Magnesium in the Pathogenesis of Metabolic Disorders.

Authors:  Marta Pelczyńska; Małgorzata Moszak; Paweł Bogdański
Journal:  Nutrients       Date:  2022-04-20       Impact factor: 6.706

2.  Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population.

Authors:  Jiancheng Xu; Wei Xu; Hanxin Yao; Weixia Sun; Qi Zhou; Lu Cai
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

3.  Moving beyond cardio: the value of resistance training, balance training, and other forms of exercise in the management of diabetes.

Authors:  Marni J Armstrong; Sheri R Colberg; Ronald J Sigal
Journal:  Diabetes Spectr       Date:  2015-01

4.  Cellular Trace Element Changes in Type 1 Diabetes Patients.

Authors:  Vahap Uğurlu; Çiğdem Binay; Enver Şimşek; Cengiz Bal
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

5.  Status of serum magnesium in Egyptian children with type 1 diabetes and its correlation to glycemic control and lipid profile.

Authors:  Doaa Shahbah; Amr Abo El Naga; Tamer Hassan; Marwa Zakaria; Mohamed Beshir; Salah Al Morshedy; Mohamed Abdalhady; Ezzat Kamel; Doaa Abdel Rahman; Lamiaa Kamel; May Abdelkader
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Magnesium deficiency and oxidative stress: an update.

Authors:  Anastasia A Zheltova; Maria V Kharitonova; Igor N Iezhitsa; Alexander A Spasov
Journal:  Biomedicine (Taipei)       Date:  2016-11-17

7.  Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia.

Authors:  Doaaa Shahbah; Tamer Hassan; Saeed Morsy; Hosam El Saadany; Manar Fathy; Ashgan Al-Ghobashy; Nahla Elsamad; Ahmed Emam; Ahmed Elhewala; Boshra Ibrahim; Sherief El Gebaly; Hany El Sayed; Hanan Ahmed
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.